Skip to main content
HSDT
NASDAQ Crypto Assets

Solana Co Q2 2026: Revenue Jumps, Net Loss Widens to $30.3M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.7
Mkt Cap
$99.257M
52W Low
$1.185
52W High
$25.5
52W Position info
43% above low
Off High info
93% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

HSDT sits 43% above its 52-week low of $1.185.

Summary

Solana Co reported Q2 2026 revenue of $2.5 million, up from $43 thousand a year ago, but net loss widened to $30.3 million. The company completed a $7.9 million offering and repurchased $2.3 million in shares, while cash reserves fell to $3.6 million.


Key Events · Earnings and Guidance · HSDT

  • Q2 Revenue Surges to $2.5M

    Revenue increased to $2.5 million from $43 thousand in Q2 2025, driven by staking revenue on SOL holdings.

  • Net Loss Widens to $30.3M

    Net loss was $30.3 million, or $0.38 per share, compared to $9.8 million a year ago, due to a $25.4 million realized loss on digital assets and higher G&A expenses.

  • Registered Direct Offering Raises $7.9M

    Completed a registered direct offering to institutional investors for net proceeds of $7.9 million, led by Mirae Asset with participation from HashKey Capital.

  • Share Repurchases Total $2.3M in Q2

    Repurchased approximately $2.3 million in shares, retiring 1.3 million shares, bringing year-to-date repurchases to $5.9 million.


Analysis · HSDT · Crypto Assets

Solana Co's Q2 results reveal a dramatic revenue surge to $2.5 million from $43 thousand a year ago, driven by staking revenue from its digital asset treasury. However, the net loss widened to $30.3 million, largely due to a $25.4 million realized loss on digital assets and $11.1 million in G&A expenses, including $6.8 million in severance from the PoNS divestiture. The company completed a $7.9 million registered direct offering and repurchased $2.3 million in shares, but cash reserves are thin at $3.6 million against ongoing operating losses. The divestiture of the legacy medical device business removes a cash drain, but the company's ability to fund operations remains a key concern.

At the time of this filing, HSDT was trading at $1.70 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $99.3M. The 52-week trading range was $1.19 to $25.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HSDT - Latest Insights

HSDT
Jun 30, 2026, 7:55 AM EDT
Source: CryptoProwl
Importance Score:
8
Price at Filing: $1.62
Real-time Price: $1.71 info
Change: +$0.090 (+6%) info
Market Cap: $99.257M info
HSDT
May 29, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.95
Real-time Price: $1.71 info
Change: -$0.240 (-12%) info
Market Cap: $99.257M info
HSDT
May 29, 2026, 5:16 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.95
Real-time Price: $1.71 info
Change: -$0.240 (-12%) info
Market Cap: $99.257M info
HSDT
May 29, 2026, 5:08 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.95
Real-time Price: $1.71 info
Change: -$0.240 (-12%) info
Market Cap: $99.257M info
HSDT
May 26, 2026, 4:18 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.71 info
Change: -$0.590 (-26%) info
Market Cap: $99.257M info